Concepedia

Publication | Open Access

Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial

DOIFull Paper Access

198

Citations

22

References

2020

Year

Alexander P. J. Vlaar, Sanne de Bruin, Matthias H. Busch, Sjoerd A.M.E.G. Timmermans, Ingeborg E. van Zeggeren, Rutger Koning, Liora ter Horst, Esther Bulle, Frank E.H.P. van Baarle, Marcel C.G. van de Poll,
The Lancet Rheumatology

References

YearCitations

Page 1